巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Walgreens Boots Alliance

    WBA
    31.970
    1.230
    3.70%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Walgreens Boots Alliance - 延遲價格・最後更新於 29/09 1:59
    最高位
    32.740
    最低位
    31.910
    開市價
    --
    前收市價
    33.200
    成交量(千)
    39.31
    成交額(百萬)
    10.02
    買入
    31.960
    賣出
    31.980
    每手股數
    --
    市值(百萬)
    27,630.29
    市盈率
    5.420
    息率
    6.13%
    差價
    --
    52週高低
    53.455 - 32.265
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Walgreens Boots Alliance
    證券代碼
    WBA.US
    所屬板塊
    Pharmaceutical Retailers
    公司業務
    Walgreens Boots Alliance is a leading retail pharmacy chain with about 13,000 stores in the U.S. and internationally. Walgreens’ core strategy involves brick-and-mortar retail pharmacy locations in high-traffic areas, with nearly 80% of the U.S. population living within 5 miles of a store. Currently, the company has a leading share of the domestic prescription drug market at about 20%. In 2021, the company sold a majority of its Alliance Healthcare wholesale business to AmerisourceBergen for $6.5 billion, doubling down on its core pharmacy efforts and ventures in strategic growth areas in primary care (VillageMD) and digital offerings. The company also has equity stakes in AmerisourceBergen (29%) and Sinopharm Holding Guoda Drugstore (40%).
    發行量
    863773464
    公司總部
    108 Wilmot Road
    公司網址
    https://www.walgreens.com
    公司電郵
    investor.relations@wba.com
    公司電話
    +1 847 315-3700

    美國法院判決沃爾瑪等公司因助長鴉片濫用賠償6.5億美元

    格隆匯·
    美國法院判決沃爾瑪等公司因助長鴉片濫用賠償6.5億美元

    美股異動 | 沃爾格林聯合博姿跌5% 第三季度利潤大降74%

    格隆匯·
    美股異動 | 沃爾格林聯合博姿跌5% 第三季度利潤大降74%

    美股異動 | 沃爾格林聯合博姿跌5% 第三季度利潤大降74%

    格隆匯·
    美股異動 | 沃爾格林聯合博姿跌5% 第三季度利潤大降74%

    每人3片!美國緊急避孕藥被限購 因需求激增

    格隆匯··精選
    每人3片!美國緊急避孕藥被限購 因需求激增

    美國百強企業CEO去年加薪近31% 英特爾CEO奪得榜首

    格隆匯··精選
    美國百強企業CEO去年加薪近31% 英特爾CEO奪得榜首

    關於

    Walgreens Boots Alliance(WBA.US)所屬的行業板塊為Pharmaceutical Retailers。
    Walgreens Boots Alliance is a leading retail pharmacy chain with about 13,000 stores in the U.S. and internationally. Walgreens’ core strategy involves brick-and-mortar retail pharmacy locations in high-traffic areas, with nearly 80% of the U.S. population living within 5 miles of a store. Currently, the company has a leading share of the domestic prescription drug market at about 20%. In 2021, the company sold a majority of its Alliance Healthcare wholesale business to AmerisourceBergen for $6.5 billion, doubling down on its core pharmacy efforts and ventures in strategic growth areas in primary care (VillageMD) and digital offerings. The company also has equity stakes in AmerisourceBergen (29%) and Sinopharm Holding Guoda Drugstore (40%).
    截至29/09 01:59:13,Walgreens Boots Alliance的股價跌-3.70,市值27,630.29百萬。Walgreens Boots Alliance的市盈率及息率分別為5.420及6.13%。
    詳細公司背景可參考: https://www.walgreens.com